← Back to Clinical Trials
Recruiting NCT06786572

NCT06786572 Interoceptive Training Enhanced Mindfulness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06786572
Status Recruiting
Phase
Sponsor Veterans Medical Research Foundation
Condition Anxiety Sensitivity
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2025-09-10
Primary Completion 2027-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Mindfulness trainingInteroceptive exposure

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2025-09-10 with a primary completion date of 2027-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This pilot randomized controlled trial will compare a novel mindfulness training to interoceptive exposure to establish feasibility and acceptability as an intervention for anxiety sensitivity.

Eligibility Criteria

Inclusion Criteria: * Veteran status * able to read and speak English * ASI-3 score of 23 or higher * clinically meaningful distress/impairment related to an emotional or somatic complaint as determined by a Clinical Global Impression Scale (CGI) of 3 or greater * Internet access via a device that can support remote study activities and ability to attend in person appointments Exclusion Criteria: * serious mental illness, including bipolar disorder or psychotic illness * current, untreated alcohol or substance use disorder * moderate-severe suicidality that would likely result in the need for urgent intervention in the next 2 months * current regular meditation practice or treatment for AS-related condition * cognitive dysfunction that interferes with the ability to engage in treatment

Contact & Investigator

Central Contact

Ariel J Lang, PhD, MPH

✉ ariel.lang@va.gov

📞 8585528585

Frequently Asked Questions

Who can join the NCT06786572 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety Sensitivity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06786572 currently recruiting?

Yes, NCT06786572 is actively recruiting participants. Contact the research team at ariel.lang@va.gov for enrollment information.

Where is the NCT06786572 trial being conducted?

This trial is being conducted at San Diego, United States.

Who is sponsoring the NCT06786572 clinical trial?

NCT06786572 is sponsored by Veterans Medical Research Foundation. The trial plans to enroll 48 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology